HCG
Healthcare Global Enterprises
Each stock's 10,000-path forecast, rendered as light.
Healthcare Global Enterprises (HCG) Stock Analysis & Case Study
Is HCG a good buy? The data-driven verdict.
on the numbers it worth a closer look, a Downstox Snapshot Score of 58/100.
On the numbers, Healthcare Global Enterprises (HCG) worth a closer look, a Downstox Snapshot Score of 58/100, weighing a 72% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027–2031.
Last updated . Data snapshot for research, not investment advice.
HCG share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 2.0y of HCG history (24%/yr drift, 32%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| HCG 2027 | ₹492 | ₹745 | ₹1,133 | +21% |
| HCG 2028 | ₹499 | ₹903 | ₹1,623 | +47% |
| HCG 2029 | ₹530 | ₹1,083 | ₹2,229 | +76% |
| HCG 2030 | ₹577 | ₹1,311 | ₹2,999 | +113% |
| HCG 2031 | ₹634 | ₹1,569 | ₹4,057 | +155% |
Median (P50) is the central estimate; the P10–P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability HCG goes up, or doubles?
The bull case for HCG
- A 10,000-path probability model puts a 72% chance the price is higher in a year, with a median target of ₹745 (+21%).
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹2,229.
The bear case & risks
- No model or past record guarantees future returns, treat this as one input, not a decision.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹530.
HCG volatility & expected range, how bumpy is the ride?
Over the last 2.0 years HCG compounded at 24%/year with annualized volatility of 32%. That volatility implies a 1-year 80% range of ₹492–₹1,133, the honest backbone behind any single price target.
HCG price forecast, the full 60-month probability fan
HCG price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds HCG hits common targets within the simulated horizon?
Full multi-horizon detail on the HCG price target & forecast page.
HCG MTF margin & leverage, Upstox, Zerodha, Groww, Dhan
Margin Trading Facility lets you buy HCG with part of the capital. Lower margin % = higher leverage. Rates compared across brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 35.0% | 2.9× |
| ZerodhaCHEAPEST | 30.0% | 3.3× |
| DhanCHEAPEST | 30.0% | 3.3× |
Compare every broker on the HCG MTF page.
HCG vs peers,sector comparison
About Healthcare Global Enterprises: sector, index & market-cap context
Healthcare Global Enterprises (HCG) is an NSE-listed company.
How the HCG Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Healthcare Global Enterprises's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
HCG analysis, FAQs
Is Healthcare Global Enterprises (HCG) a good buy?
On the numbers, Healthcare Global Enterprises (HCG) worth a closer look, a Downstox Snapshot Score of 58/100, weighing a 72% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is HCG overvalued or undervalued?
Valuation ratios for HCG are tracked live on Downstox.
What is the HCG share price target for 2031?
HCG's probability-weighted 2031 median target is ₹1,569, with an 80% range of ₹634–₹4,057 (10,000-path Monte-Carlo).
What is the probability HCG doubles in 5 years?
The modelled probability of HCG reaching ₹1,231 (2×) within 5 years is 64%.
What is the bull case for HCG?
A 10,000-path probability model puts a 72% chance the price is higher in a year, with a median target of ₹745 (+21%).
What are the risks in HCG?
No model or past record guarantees future returns, treat this as one input, not a decision.